Related references
Note: Only part of the references are listed.Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain
Nanaocha Sharma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection
Michael H. Lehmann et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Blockade of Interferon Beta, but Not Interferon Alpha, Signaling Controls Persistent Viral Infection
Cherie T. Ng et al.
CELL HOST & MICROBE (2015)
IFN-β and multiple sclerosis: From etiology to therapy and back
V. Annibali et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Interfering with Immunity: Detrimental Role of Type I IFNs during Infection
Sebastian A. Stifter et al.
JOURNAL OF IMMUNOLOGY (2015)
Pharmacological Inhibition of Type I Interferon Signaling Protects Mice Against Lethal Sepsis
Lien Dejager et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Purification and biological characterization of soluble, recombinant mouse IFNβ expressed in insect cells
Sebastian A. Stifter et al.
PROTEIN EXPRESSION AND PURIFICATION (2014)
Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist
Doron Levin et al.
SCIENCE SIGNALING (2014)
The pathological effects of CCR2+inflammatory monocytes are amplified by an IFNAR1-triggered chemokine feedback loop in highly pathogenic influenza infection
Sue-Jane Lin et al.
JOURNAL OF BIOMEDICAL SCIENCE (2014)
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
HyeonJoo Cheon et al.
EMBO JOURNAL (2013)
Toll-like receptor signaling adapter proteins govern spread of neuropathic pain and recovery following nerve injury in male mice
Jennifer A. Stokes et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1
Nicole A. de Weerd et al.
NATURE IMMUNOLOGY (2013)
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
Elizabeth B. Wilson et al.
SCIENCE (2013)
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
Bradley N. Bidwell et al.
NATURE MEDICINE (2012)
Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons
Christoph Thomas et al.
CELL (2011)
Suppressor of Cytokine Signaling (SOCS) 1 Inhibits Type I Interferon (IFN) Signaling via the Interferon α Receptor (IFNAR1)-associated Tyrosine Kinase Tyk2
Rebecca A. R. Piganis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Injury-Induced Type I IFN Signaling Regulates Inflammatory Responses in the Central Nervous System
Reza Khorooshi et al.
JOURNAL OF IMMUNOLOGY (2010)
A conserved IFN-α receptor tyrosine motif directs the biological response to type IIFNs
Wenli Zhao et al.
JOURNAL OF IMMUNOLOGY (2008)
Comparable potency of IFNα2 and IFNß on immediate JAK/STAT activation but differential down-regulation of IFNAR2
Zrinka Marijanovic et al.
BIOCHEMICAL JOURNAL (2007)
Upregulation of a small subset of genes drives type I interferon-induced antiviral memory
Diego A. Jaitin et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2007)
The interferons: 50 years after their discovery, there is much more to learn
Sidney Pestka
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Should we inhibit type I interferons in sepsis?
Tina Mahieu et al.
INFECTION AND IMMUNITY (2007)
Blocking monoclonal antibodies specific for mouse IFN-α/β receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection
Kathleen C. F. Sheehan et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)
Statistical analysis of real-time PCR data
JS Yuan et al.
BMC BIOINFORMATICS (2006)
The wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN-β production
T Mahieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Interferon-α and -β differentially regulate osteoclastogenesis:: Role of differential induction of chemokine CXCL11 expression
LFL Coelho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Functional cartography of the ectodornain of the type I interferon receptor subunit ifnar1
P Lamken et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Critical roles for IFN-β in lymphoid development, myelopoiesis, and tumor development:: Links to tumor necrosis factor α
R Deonarain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
M Karaghiosoff et al.
NATURE IMMUNOLOGY (2003)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities
E Jonasch et al.
ONCOLOGIST (2001)